A detailed history of Stiles Financial Services Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Stiles Financial Services Inc holds 5,221 shares of ABBV stock, worth $939,780. This represents 0.37% of its overall portfolio holdings.

Number of Shares
5,221
Previous 5,902 11.54%
Holding current value
$939,780
Previous $1.01 Million 1.88%
% of portfolio
0.37%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $111,575 - $135,743
-681 Reduced 11.54%
5,221 $1.03 Million
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $66,714 - $77,907
-431 Reduced 6.81%
5,902 $1.01 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $129,614 - $147,683
-811 Reduced 11.35%
6,333 $1.15 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $211,491 - $238,188
-1,537 Reduced 17.71%
7,144 $1.11 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $329,833 - $381,830
-2,469 Reduced 22.14%
8,681 $1.29 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $196,114 - $244,052
1,480 Added 15.31%
11,150 $1.5 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $8,965 - $10,325
62 Added 0.65%
9,670 $1.54 Million
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $55,462 - $66,513
401 Added 4.36%
9,608 $0
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $416,319 - $477,490
3,102 Added 50.81%
9,207 $1.24 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $48,855 - $62,110
355 Added 6.17%
6,105 $935,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $23,756 - $29,475
180 Added 3.23%
5,750 $932,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $598,385 - $757,130
5,570 New
5,570 $754,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stiles Financial Services Inc Portfolio

Follow Stiles Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stiles Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stiles Financial Services Inc with notifications on news.